September 11, 2009
12:00 noon
Registration Opens/Lunch (provided)
1:00 p.m.
Welcome and Introductions
James N. George, MD, Program Co-Chair
Past President, American Society of Hematology
Douglas B. Cines, MD, Program Co-Chair
1:10 p.m.
Acute Lymphoblastic Leukemia (ALL)
Dan Douer, MD
University of Southern California
1:50 p.m.
Chronic Myeloid Leukemia (CML)
Michael J. Mauro, MD
Oregon Health and Science University
2:30 p.m.
Acute Myeloid Leukemia (AML)
Martin S. Tallman, MD
Northwestern University
3:10 p.m.
Panel Discussion
3:25 p.m.
Break and Exhibits Open
3:45 p.m.
Platelet Disorders: Idiopathic Thrombocytopenia (ITP)
Douglas B. Cines, MD
University of Pennsylvania Hospital
4:25 p.m.
Platelet Disorders: Heparin-Induced Thrombocytopenia (HIT)
Gowthami Arepally, MD
Duke University Medical Center
5:05 p.m.
Platelet Disorders: Thrombotic Thrombocytopenic Purpura (TTP)
James N. George, MD
University of Oklahoma
5:45 p.m.
Panel Discussion
6:00 p.m.
Welcome Reception and Exhibits
All Speakers and Attendees
September 12, 2009
7:00 a.m.
Breakfast With the Experts
All Speakers and Attendees
8:00 a.m.
Announcements and Introductions
Martin S. Tallman, MD, Program Co-Chair
8:05 a.m.
Practice Update
James N. George, MD
Past President, American Society of Hematology
8:15 a.m.
Hodgkin Lymphoma
Nancy L. Bartlett, MD
Washington University
8:55 a.m.
Follicular Lymphoma
Peter McLaughlin, MD
The University of Texas M. D. Anderson Cancer Center
9:35 a.m.
Diffuse Large B-Cell Lymphoma
Laurie Sehn, MD
British Columbia Cancer Agency
10:15 a.m.
Break and Exhibits Open
10:35 a.m.
T-Cell Lymphoma
Ranjana Advani, MD
Stanford University
11:15 a.m.
Mantle Cell Lymphoma
Steven H. Bernstein, MD
University of Rochester
11:55 a.m.
Panel Discussion
12:15 p.m.
Lunch (provided) and Exhibits Open
1:15 p.m.
Marginal Zone and Lymphoplasmacytic Lymphomas
Sonali Smith, MD
University of Chicago
1:55 p.m.
Stem Cell Transplantation for Lymphoma
Hillard M. Lazarus, MD
University Hospitals Case Medical Center
2:35 p.m.
Break
2:50 p.m.
Myeloma: Management Transplant-Eligible Patients
Robert Z. Orlowski, MD, PhD
MD Anderson Cancer Center
3:30 p.m.
Myeloma: Management Transplant-Ineligible Patients
Donna E. Reece, MD
Princess Margaret Hospital
4:10 p.m.
Panel Discussion
4:30 p.m.
Symposium Adjourned